Clinical Trial Update: A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke. [Phase 4]

View source ↗

Summary

A Phase 4 safety study of Ginkgolides Meglumine Injection for ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ginkgolides Meglumine Injection (ginkgolide meglumine)

Snippet

Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd | Conditions: Ischemic Stroke | Phase 4 | Status: COMPLETED